The Union Budget 2026-27 focuses on fortifying the Indian economy against global volatility through strategic investments in technology, he...

India's new budget prioritizes long-term growth through investment in people. It emphasizes skills, education, and healthcare to boost prod...

India is set to become a global biopharmaceutical manufacturing hub. Finance Minister Nirmala Sitharaman announced a dedicated ₹10,000 cror...

India Inc has welcomed the Union Budget 2026-27. Industry leaders believe it is a budget for the real economy. It focuses on enhancing Indi...

LIC CEO & MD R Doraiswamy described the Union Budget as a visionary roadmap for India's ambition to become a top three global economy. He h...

The Union Budget 2026-27 signals a major policy shift, focusing on healthcare as a key economic growth driver. Finance Minister Nirmala Sit...

With its 2026 Union Budget, India places a spotlight on the future of healthcare, specifically targeting biologics and biosimilars. A visio...

India's biopharmaceutical sector receives a significant boost with the Union Budget's ₹10,000 crore Biopharma SHAKTI programme. This initia...

India Budget 2026: India's drug regulatory authority, CDSCO, will be strengthened to meet global standards and speed up approvals. A new in...

Union Budget 2026: With the announcement of the 'Biopharma Shakti' initiative, India is gearing up to take the world stage in biopharmaceut...

Indian healthcare stocks surged following the Union Budget 2026 announcement of measures to boost medical tourism. The government plans to ...

Finance Minister Nirmala Sitharaman announced plans for five regional medical tourism hubs. A Rs 10,000 crore Biopharma Shakti program will...

The proposed fund aims to position India as a global biopharma manufacturing hub

Union Budget 2026: Finance Minister Nirmala Sitharaman has presented a six-point plan to boost India's economy. The strategy prioritizes ma...

“A phenomenal increase in the government's capital expenditure is likely to facilitate the expenditures on infrastructure and create jobs. ...

Ahead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...

India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US, that preve...